Ruel Jacob wrote a new post 1 year, 7 months ago
Trastuzumab Deruxtecan Meets Objective Response Rate Endpoint in Several Types of HER2-expressing Advanced Solid Tumours
Positive topline results of the ongoing DESTINY-PanTumour02 Phase II trial (NCT04482309) showed that treatment with trastuzumab deruxtecan met the […]-
Ruel Jacob wrote a new post 1 year, 7 months ago
The First International Management Guidelines for Early-Onset Colorectal Cancer
This March, the Clinical Gastroenterology and Hepatology journal published the first management guidelines for Early-Onset Colorectal Cancer […] -
Ruel Jacob wrote a new post 1 year, 7 months ago
FAPA – Familial Adenomatous Polyposis Association rang in 30 years as a scientific and patient organisation with […] -
Ruel Jacob wrote a new post 1 year, 8 months ago
The combination of durvalumab (Imfinzi) and tremelimumab (Imjudo) immunotherapies has been approved by the […] -
Ruel Jacob wrote a new post 1 year, 8 months ago
Zolbetuximab Plus Chemotherapy Extends Overall Survival for Patients with Advanced or Metastatic Gastric & Gastro-oesophageal Junction Adenocarcinoma
The Annual American Society of Clinical Oncologists Gastrointestinal Cancers Symposium (ASCO GI) kicked off the year with lots of new data in the […] 
Natasha Muench wrote a new post 1 year, 8 months ago
The devastating earthquakes that struck southern Turkey and northern Syria on 6 February have destroyed homes, […]
Aleksandra Kaczmarek wrote a new post 1 year, 8 months ago
<strong>How Is Your Country Doing? Launch of European Country Cancer Profiles</strong>
Together with nearly 200 participants, DiCE joined the online launch of Country Cancer Profiles on the European Cancer Inequalities Registry. The […]-
Aleksandra Kaczmarek wrote a new post 1 year, 8 months ago
<strong>European Commission Gathered Evidence on Vaccine-preventable Cancers</strong>
As part of Europe’s Beating Cancer Plan, the European Commission started work on future Council Recommendations […] -
Natasha Muench wrote a new post 1 year, 8 months ago
<strong>DiCE Supports Act4Biosimilars to Increase Patient Access to Biologic Medicines</strong>
Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater […] -
Natasha Muench wrote a new post 1 year, 8 months ago
<strong>16 February is World Cholangiocarcinoma Day</strong>
16 February is World Cholangiocarcinoma (CCA) Day. World CCA Day was previously held on 12 February. However, […] -
Haidar Akl wrote a new post 1 year, 9 months ago
Interventions to Reduce Cancer Screening Inequities
A group of patients and patient advocacy organisations published a promising multistep strategy to reduce cancer screening inequalities In […] -
Ruel Jacob wrote a new post 1 year, 9 months ago
<strong>First Immunotherapy Drug Durvalumab Plus Chemotherapy Approved in Europe for Advanced Biliary Cancer</strong>
On 21 December the European Commission (EC) approved the use of durvalumab (Imfinzi ®) plus chemotherapy (gemcitabine plus cisplatin) as the first […] -
Ruel Jacob wrote a new post 1 year, 9 months ago
<strong>Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer</strong>
On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin) […] -
Ruel Jacob wrote a new post 1 year, 10 months ago
Find your people!CRC Patients and caregivers, join the European community of COLONTOWN!
COLONTOWN is an international community of colorectal cancer patients and their […]
-
Ruel Jacob wrote a new post 1 year, 11 months ago
News From The North, PALEMA’s Tireless Efforts During The Months of October and November.October and November were busy months for our Swedish member […]
-
Ruel Jacob wrote a new post 1 year, 11 months ago
Would you like to know how and where patient engagement is happening in R&D? Would you like to see an objective comparison between Europe and Japan? National Cancer Centre Japan needs your support to promote t […]
-
Ruel Jacob wrote a new post 1 year, 11 months ago
For the 2022 edition, we received five great projects from Belgium, France, Italy and Portugal, respectively. Results were tight among the jury. One project, however, exceeded the others with the highest score: […]
-
Ruel Jacob wrote a new post 1 year, 11 months ago
The European Commission adopted the 2023 EU4Health work programme. It lists in detail all working streams and activities planned by DG SANTE in the area of health.The […]
-
Ruel Jacob wrote a new post 1 year, 11 months ago
Digestive Health Community Support for the Proposed EU Cancer Screening Recommendations
In September, as part of Europe’s Beating Cancer Plan, the European Commission presented updated EU Cancer […] -
Ruel Jacob wrote a new post 1 year, 12 months ago
- Load More
